Watchman Left Atrial Appendage: Completed Phase III enrollment

Boston Scientific completed enrollment of 407 high-risk AF patients in the open-label, U.S. Phase III PREVAIL trial comparing Watchman Left Atrial Appendage (LAA) Closure Technology vs. long-term warf...